Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization

Acta Histochemica

Volumn 105, Issue 1, 2003, Pages 67-72

  Zhang, Xiao Ying ^a   Dong, Xuan ^a   Zheng, Lu ^a   Luo, Guang Hua ^a   Liu, Yuan Hua ^a   Ekström, Ulf ^b   Nilsson Ehle, Peter ^b   Ye, Qing ^a   Xu, Ning ^b  

^a SOOCHOW UNIVERSITY   (China)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apolipoprotein M; In situ hybridization; Kidney; Liver

Indexed keywords

CELLS; GENES; HISTOLOGY; PATHOLOGY; TISSUE;

CELLULAR LOCALIZATION;

PROTEINS;

APOLIPOPROTEIN; APOLIPOPROTEIN M; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY EPITHELIUM; LIVER CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

MAMMALIA;

EID: 0037219269     PISSN: 00651281     EISSN: None     Source Type: Journal    
DOI: 10.1078/0065-1281-00687     Document Type: Article

References (16)

1. Babiak J, and Rudel LL (1987) Lipoproteins and atherosclerosis. Baillieres Clin Endocrinol Metab 1: 515-550
2. de Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, and Taylor JM (1994) Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem 269: 2324-2335
3. Duan J, Dahlback B, and Villoutreix BO (2001) Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett 499: 127-132
4. Duchateau PN, Movsesyan I, Yamashita S, Sakai N, Hirano KI, Schoenhaus SA, O'Connor-Kearns PM, Spencer SJ, Jaffe RB, Redberg RE Ishida BY, Matsuzawa Y, Kane JP, and Malloy MJ (2000) Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res 41: 1231-1236
5. Duchateau PN, Pullinger CR, Orellana RE, Kunitake ST, Naya-Vigne J, O'Connor PM, Malloy MJ, and Kane JP (1997) Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem 272: 25576-25582
6. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, and Bisgaier CL (1990) Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 265:4266-4272
7. Kawashiri MA, Maugeais C, and Rader DJ (2000) High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis. Curr Atheroscler Rep 2: 363-372
8. Koren E, McConathy WJ, and Alaupovic P (1982) Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. Biochemistry 21: 5347-5351
9. Mahley RW (1997) The J. David Gladstone Institutes. Mol Med 3: 569-571
10. Mahley RW (1981) Cellular and molecular biology of lipoprotein metabolism in atherosclerosis. Diabetes 30: 60-65
11. Miller NE (1987) High-density lipoprotein: a major risk factor for coronary atherosclerosis. Baillieres Clin Endocrinol Metab 1: 603-622
12. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, and Milne R (2000) Apolipoprotein D. Biochim Biophys Acta 1482: 185-198
13. Wang X, Driscoll DM, and Morton RE (1999) Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F. J Biol Chem 274: 1814-1820
14. Weng W, Brandenburg NA, Zhong S, Halkias J, Wu L, Jiang XC, Tall A, and Breslow JL (1999) ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice. J Lipid Res 40: 1064-1070
15. Xu N, and Dahlback B (1999) A novel human apolipoprotein (apoM). J Biol Chem 274: 31286-31290
16. Xu N, Zhang XY, Dong X, Ekstrom U, Ye Q, and Nilsson-Ehle P (2002) Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. Biochem Biophys Res Commun 292: 944-950